Evidence map›Paper›PMID 41369850›Full record

ArticleEJNMMI radiopharmacy and chemistry2025

Establishing Pb-203 production from electrodeposited Tl targets at Brookhaven National Laboratory.

Wilson Lin, Dmitri G Medvedev, Cathy S Cutler, Jasmine Hatcher-Lamarre

Abstract read
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wilson LinBrookhaven National Laboratory, Upton, NY, 11973, USA. wlin4@bnl.gov.ORCID http://orcid.org/0000-0003-4049-9355
Dmitri G MedvedevBrookhaven National Laboratory, Upton, NY, 11973, USA.
Cathy S CutlerBrookhaven National Laboratory, Upton, NY, 11973, USA.
Jasmine Hatcher-LamarreBrookhaven National Laboratory, Upton, NY, 11973, USA.

Funding

Office of Isotope R and D and Production Office of Isotope R and D and Production
6 · The paper itself

Abstract

backgroundPromising developments in Pb-212 radiopharmaceutical therapies have increased demand for Pb-203 diagnostic agents. Building on previous work from various isotope production facilities, this study optimized Pb-203 production from electrodeposited Tl targets at Brookhaven National Laboratory (BNL). The additional supply of Pb-203 may help meet growing preclinical and clinical demands.

resultsTwo Tl targets were irradiated at the Brookhaven Linac Isotope Producer facility with 30 ± 1 MeV protons, measured using previously published cross section data. Distribution coefficients for Pb Resin in acetate media were investigated for both Na

conclusionsThe production and separation of Pb-203 from natural Tl target material was successfully demonstrated at BNL. Existing methods were adapted and optimized for the facilities at BNL. Results from this work will guide future large-scale Pb-203 production opportunities at BNL for clinical applications.

Indexed as

BLIPChromatographyPb-203RadiopharmaceuticalThallium electrodepositionTheragnostic

Identifiers

PMID41369850
PMCPMC12696209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.